Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuki Nagata
Observed name:
Nagata, Yuki
Institution:
Institute of Science Tokyo
Observed institutions:
Tokyo Medical and Dental University,
National Center for Geriatrics and Gerontology,
Institute of Science Tokyo,
Medical Genome Center, National Center for Geriatrics and Gerontology,
Research Institute, National Center for Geriatrics and Gerontology
ORCID:
0000-0002-7859-9661
Observed ORCID:
0000-0002-7859-9661
OpenAlex ID:
A5037644594
Works
65
Awards
1
Comparative analysis of cerebrospinal fluid metabolites in Alzheimer’s disease and idiopathic normal pressure hydrocephalus in a Japanese cohort
2018
·
Yuki Nagata
, Akiyoshi Hirayama
, et al.
·
Biomarker Research
·
45
PDF
Brugada syndrome in Japan and Europe: a genome-wide association study reveals shared genetic architecture and new risk loci
2024
·
Taisuke Ishikawa
, Tatsuo Masuda
, et al.
·
European Heart Journal
·
25
PDF
Interleukin-1beta (IL-1β)-induced Notch ligand Jagged1 suppresses mitogenic action of IL-1β on human dystrophic myogenic cells
2017
·
Yuki Nagata
, Tohru Kiyono
, et al.
·
PLoS ONE
·
23
PDF
PTPRQ as a potential biomarker for idiopathic normal pressure hydrocephalus
2017
·
Yuki Nagata
, Masahiko Bundo
, et al.
·
Molecular Medicine Reports
·
18
PDF
Differential impact of the Bisphosphonate Alendronate on undifferentiated and terminally differentiated human myogenic cells
2013
·
Kosuke Shiomi
, Yuki Nagata
, et al.
·
Journal of Pharmacy and Pharmacology
·
16
EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025
·
Kosuke Arai
, Yukari Nishito
, et al.
·
Cancer Immunology Research
·
10
Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments
2024
·
Hironori Fukuda
, Kosuke Arai
, et al.
·
Cancer Science
·
10
High serum gamma‐glutamyltransferase level after hepatitis C virus elimination is a risk factor for the development of hepatocellular carcinoma
2024
·
Miyako Murakawa
, Mina Nakagawa
, et al.
·
Hepatology Research
·
8
Identification of OPN3 as associated with non-syndromic oligodontia in a Japanese population
2021
·
Yumi Inagaki
, Takuya Ogawa
, et al.
·
Journal of Human Genetics
·
8
Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations
2023
·
Kazunori Aoki
, Yukari Nishito
, et al.
·
Cancer Research Communications
·
6
PDF
Targeted deep sequencing analyses of long QT syndrome in a Japanese population
2022
·
Yuki Nagata
, Ryo Watanabe
, et al.
·
PLoS ONE
·
4
PDF
Prediction of Paroxysmal Atrial Fibrillation With Incorporating Genomic Information Into AI-Based ECG Analysis
2026
·
Kensuke Ihara
, Yuki Nagata
, et al.
·
JACC Asia
·
1
PDF
Protocadherin alpha gene cluster variants are potentially associated with short root anomaly in Japanese
2025
·
Yuki Ikeda-Sagawa
, Takuya Ogawa
, et al.
·
European Journal of Orthodontics
·
1
Correction to: Identification of OPN3 as associated with non-syndromic oligodontia in a Japanese population
2021
·
Yumi Inagaki
, Takuya Ogawa
, et al.
·
Journal of Human Genetics
·
1
PDF
Supplementary Figure S12 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025
·
Kosuke Arai
, Yukari Nishito
, et al.
PDF
Supplementary Figure S1 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025
·
Kosuke Arai
, Yukari Nishito
, et al.
PDF
Supplementary Figure S11 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025
·
Kosuke Arai
, Yukari Nishito
, et al.
PDF
Supplementary Table S2 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025
·
Kosuke Arai
, Yukari Nishito
, et al.
PDF
Supplementary Figure S3 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025
·
Kosuke Arai
, Yukari Nishito
, et al.
PDF
Supplementary Figure S6 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025
·
Kosuke Arai
, Yukari Nishito
, et al.
PDF
Supplementary Figure S7 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025
·
Kosuke Arai
, Yukari Nishito
, et al.
PDF
Supplementary Figure S4 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025
·
Kosuke Arai
, Yukari Nishito
, et al.
PDF
Supplementary Figure S10 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025
·
Kosuke Arai
, Yukari Nishito
, et al.
PDF
Supplementary Figure S8 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025
·
Kosuke Arai
, Yukari Nishito
, et al.
Data from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025
·
Kosuke Arai
, Yukari Nishito
, et al.
Show more works
View as search
Works count:
65
Citation count:
176
H-index:
8
I10-index:
7
Year
Topic
Type